AmerisourceBergen Corporation – Consensus Indicates Potential 22.6% Upside
AmerisourceBergen Corporation found using ticker (ABC) now have 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 188 and 150 calculating the average target price we see 170.75. With the stocks previous close at 139.27 this would indicate that there is a potential upside of 22.6%. The 50 day MA is 144.36 and the 200 day moving average is 140.67. The market cap for the company is $29,288m. You can visit the company''s website by visiting: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,908m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
AmerisourceBergen Corporation – Consensus Indicates Potential 22.6% Upside
AmerisourceBergen Corporation found using ticker (ABC) now have 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 188 and 150 calculating the average target price we see 170.75. With the stocks previous close at 139.27 this would indicate that there is a potential upside of 22.6%. The 50 day MA is 144.36 and the 200 day moving average is 140.67. The market cap for the company is $29,288m. You can visit the company''s website by visiting: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,908m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.